MPWT
MED icon

MassMutual Private Wealth & Trust’s Medifast MED Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-83
Closed -$886 – 2459
2025
Q4 		$886 Sell
83
-21
-20% -$251 ﹤0.01% 2162
2025
Q3 		$1.42K Hold
104
– – ﹤0.01% 2072
2025
Q2 		$1.46K Buy
+104
New +$1.37K ﹤0.01% 2031
2024
Q3 		– Sell
-174
Closed -$3.8K – 2215
2024
Q2 		$3.8K Buy
174
+13
+8% +$347 ﹤0.01% 1408
2024
Q1 		$6.17K Buy
161
+139
+632% +$6.73K ﹤0.01% 1195
2023
Q4 		$1.48K Buy
22
+2
+10% +$139 ﹤0.01% 1597
2023
Q3 		$1.5K Sell
20
-5
-20% -$444 ﹤0.01% 1583
2023
Q2 		$2.3K Buy
25
+12
+92% +$1.07K ﹤0.01% 1433
2023
Q1 		$1.35K Sell
13
-24
-65% -$2.66K ﹤0.01% 1526
2022
Q4 		$4K Buy
37
+19
+106% +$2.21K ﹤0.01% 1081
2022
Q3 		$2K Sell
18
-3
-14% -$430 ﹤0.01% 1240
2022
Q2 		$4K Buy
21
+5
+31% +$895 ﹤0.01% 974
2022
Q1 		$3K Buy
+16
New +$3.02K ﹤0.01% 1067

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

MassMutual Private Wealth & Trust's MED Position: Q1 2026 in Review

MassMutual Private Wealth & Trust sold out of Medifast (MED) in Q1 2026, closing a stake of 83 shares — an estimated $886 sold.

MassMutual Private Wealth & Trust first reported a position in MED in Q1 2022 and held it in 13 quarters. The position peaked at $6.17K in Q1 2024. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.

  • MassMutual Private Wealth & Trust reported no remaining Medifast position as of Q1 2026 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 83 Medifast shares in Q1 2026, an estimated $886.
  • MassMutual Private Wealth & Trust first reported a position in Medifast in Q1 2022 and held it in 13 quarters.
  • MassMutual Private Wealth & Trust's Medifast position peaked at $6.17K in Q1 2024.
  • 111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2026, filed 13 Apr 2026.